SLNO
Soleno Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.51 / 10
Netural
Sentiment is neutral (5.51) while fund flow is good (7.62), with balanced overall inflow (~0.5) and positive block and large‑size buying. Analysts are split 50% Strong Buy, 50% Buy, yet historical win rates hover around 0‑50%, indicating mixed confidence.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionWells Fargo
Times predicted4
Historical Win Rate50.0%
What is the market sentiment for SLNO?
- SLNO holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.51/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
